| RESERVED AREA | LANGUAGE

Lung Cancer Study Group

Have you read THORAC’s October Article of the Month yet?

THORAC’s Article of the Month, “Lung Cancer and Immunotherapy: When the Immune System Becomes the New Challenge,” presents a case report highlighting the challenges associated with immune-mediated toxicities in lung cancer treatment.

The authors describe a patient with metastatic lung adenocarcinoma treated with pembrolizumab who developed autoimmune diabetes and bilateral immune-mediated keratitis. The case reinforces the importance of early recognition of these toxicities and a multidisciplinary approach to their management.

Read the full article here!

Posted in notícias, Thorac
Lung Cancer Study Group